FLUI — Fluicell AB Share News
0.000.00%
Last trade - 00:00- SEK53.30m
- SEK52.00m
- SEK6.00m
Brief: Committee Proposes Niklas Frisk As Fluicell Chairman
Brief: Fluicell Q4 Net Sales SEK 3.8 Mln
Brief: Fluicell Gets EPO Approval For Microfluidics Patent
Brief: Fluicell Q3 Operating Income SEK 2.3 Million
Brief: Fluicell Expects 2026 Cash Flow Between SEK -1 Mln-1 Mln
Brief: Fluicell Gets SEK 2 Mln Order From Francis Crick Institute
Brief: Fluicell Enters Exclusive Global Agreement With Ambusol For Cancer Treatment
Brief: Fluicell Q2 EBITDA Loss SEK 2.73 Mln
Brief: Fluicell Board, Management Buy 17,270 Shares Valued At SEK 188,000
Brief: Fluicell Q1 EBITDA Loss SEK 2.5 Mln
Brief: Fluicell Announces Reverse Stock Split 1:350
Brief: Fluicell Is Granted EU Patent For 3D Biological Tissue Technology
Brief: Fluicell Gets $60,000 Order From US Contract Research Organization
Brief: Fluicell Q3 EBITDA Loss Narrows To SEK 0.9 Mln
Brief: Fluicell - Outcome Of Exercise Of Warrants
Brief: Fluicell Gets SEK 2.7 Mln In Retroactive Research Tax Credit
Brief: Fluicell Receives 'Intention To Grant' From European Patent Office
Brief: Fluicell Is Granted Patent In US For Nexocyte Platform
Brief: Fluicell Decides On Directed Issue Of Shares To Guarantor